Cart
sales@molnova.com
Antimalarial agent 13
CAS No. 431884-01-4
Antimalarial agent 13( N2-(3-chlorophenyl)-N4-(furan-2-ylmethyl)quinazoline-2,4-diamine )
Catalog No. M29005 CAS No. 431884-01-4
N2-(3-chlorophenyl)-N4-(furan-2-ylmethyl)quinazoline-2,4-diamine (antimalarial agent 13 ) is a potent antimalarial agent.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 393 | Get Quote |
|
| 10MG | 581 | Get Quote |
|
| 25MG | 888 | Get Quote |
|
| 50MG | 1242 | Get Quote |
|
| 100MG | 1674 | Get Quote |
|
| 500MG | 3348 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAntimalarial agent 13
-
NoteResearch use only, not for human use.
-
Brief DescriptionN2-(3-chlorophenyl)-N4-(furan-2-ylmethyl)quinazoline-2,4-diamine (antimalarial agent 13 ) is a potent antimalarial agent.
-
DescriptionN2-(3-chlorophenyl)-N4-(furan-2-ylmethyl)quinazoline-2,4-diamine (antimalarial agent 13 ) is a potent antimalarial agent.
-
In Vitro——
-
In Vivo——
-
SynonymsN2-(3-chlorophenyl)-N4-(furan-2-ylmethyl)quinazoline-2,4-diamine
-
PathwayMicrobiology/Virology
-
TargetParasite
-
RecptorParasite
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number431884-01-4
-
Formula Weight350.8
-
Molecular FormulaC19H15ClN4O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESClc1cc(Nc2nc3ccccc3c(NCc3ccco3)n2)ccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
UCB7362 hydrochlorid...
UCB7362 hydrochloride （UCB7362 HCl） is an orally active plasmepsin X (PMX) inhibitor (IC50: 7 nM) with antimalarial activity that inhibits parasite growth.
-
N-(2-Hydroxypropyl)m...
N-(2-Hydroxypropyl)methacrylamide is used in the synthesis of copolymers for the targeted delivery of antileishmanial agents in Visceral leishmaniasis.
-
ZY-19489
ZY-19489 is an antimalarial compound that is a potential single-dose cure for Plasmodium falciparum and Plasmodium vivax malaria. It has received orphan drug designation from the FDA.
